DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/14d7cf/italy_pharmaceutic) has announced the addition of the "Italy Pharmaceuticals and Healthcare Report Q4 2011" report to their offering.
Business Monitor International's Italy Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Italy's pharmaceuticals and healthcare industry.
BMI believe the Italian government's decision to implement further austerity measures is a necessary and prudent course of action - Italy maintains one of the largest sovereign debt loads in the world and continues to receive negative attention from bond markets. However, its decision to further target the healthcare sector will not sit well with companies and patients.
BMI Economic View: The Italian economy continues to underperform compared to its regional peers, echoing its laggard status during the credit boom years. While this is in part because of the large degree of slack in the economy and wider reaching concerns about the political crisis, there are also deep structural issues at play, such as the previous erosion in productivity and overvalued real effective exchange rate. As a result BMI have revised down their medium-term growth forecasts to reflect these impediments.
BMI Political View: Having been rocked by their leader's sex scandal and corruption trials, the Italian government has been dealt a further blow by crushing defeats in local elections and four key referendums. BMI continue to believe that Prime Minister Silvio Berlusconi's time in frontline politics is drawing to a close, and warn that junior coalition partner, the Northern League, could yet decide to pull out of government in a bid to force early elections.
Key Topics Covered:
1. Executive Summary
2. SWOT Analysis
3. Pharmaceutical Business Environment Ratings
4. Italy - Market Summary
5. Regulatory Regime
6. Industry Developments
7. Industry Forecast Scenario
8. Competitive Landscape
9. Company Profiles
10. Country Snapshot: Italy Demographic Data
Companies Mentioned:
- Recordati
- Menarini
- Leading Multinational Manufacturers
- GlaxoSmithKline
- Pfizer
- Novartis
- Sanofi-Aventis
- Merck & Co
For more information visit http://www.researchandmarkets.com/research/14d7cf/italy_pharmaceutic